Can Preferentially Prescribing Angiotensin II Receptor Blockers (ARBs) over Angiotensin-Converting Enzyme Inhibitors (ACEIs) Decrease Dementia Risk and Improve Brain Health Equity?
Can Preferentially Prescribing Angiotensin II Receptor Blockers (ARBs) over Angiotensin-Converting Enzyme Inhibitors (ACEIs) Decrease Dementia Risk and Improve Brain Health Equity?
复制标题
DOI：
10.31478/202205c
复制
发表时间：
2022-01-01
期刊：
影响因子：
--
通讯作者：
Bress, Adam P
中科院分区：
文献类型：
--
作者：
Marcum, Zachary A;Cohen, Jordana B;Bress, Adam P
